Skip to main content

Kamada Ltd

KMDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001567529

In the last 90 days, Kamada Ltd insiders filed 0 open-market purchases and 2 sales; 51 institutions reported holding it in 13F filings for Q2 2026, worth $36.7M in total; ARK Invest is the only superinvestor holding it.

Q4 2021 vs. Q3 2021

How the institutions holding Kamada Ltd changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of KMDA: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders4746−1
Shares7.69M6.62M−1.07M (−13.9%)
Value$40.7M$43.6M+$2.83M (+6.9%)

New holders (6)

Institutions that held Kamada Ltd at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to KMDA in Q4 2021
InstitutionSharesValue% of portfolio
Metis Global Partners, LLC27,678$183.0K0.05%
Noked Capital LTD16,748$110.0K0.03%
Noked Israel Ltd16,748$110.0K0.03%
Marshall Wace, LLP11,046$73.0K0.00%
UBS Group AG3,281$22.0K0.00%
Sargent Bickham Lagudis LLC119$1.00K0.00%

Sold out (7)

Institutions that held Kamada Ltd at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of KMDA in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Altshuler Shaham Ltd927,474$4.94M
Seizert Capital Partners, LLC156,175$828.0K
Wolverine Trading, LLC26,355$141.0K
Citadel Advisors LLC12,465$66.0K
Penserra Capital Management LLC1,025$5.00K
Barclays PLC6$0
Prentice Wealth Management LLC20–